Search

Phuong N. Huynh

Examiner (ID: 3827, Phone: (571)272-0846 , Office: P/1644 )

Most Active Art Unit
1644
Art Unit(s)
1641, 1644
Total Applications
2195
Issued Applications
1131
Pending Applications
251
Abandoned Applications
828

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8713072 [patent_doc_number] => 08399211 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use' [patent_app_type] => utility [patent_app_number] => 12/586459 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 12032 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12586459 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/586459
Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use Sep 21, 2009 Issued
Array ( [id] => 8199890 [patent_doc_number] => 08187597 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Combination therapy for the treatment of ocular neovascular disorders' [patent_app_type] => utility [patent_app_number] => 12/564863 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 24 [patent_no_of_words] => 31651 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/187/08187597.pdf [firstpage_image] =>[orig_patent_app_number] => 12564863 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/564863
Combination therapy for the treatment of ocular neovascular disorders Sep 21, 2009 Issued
Array ( [id] => 6301978 [patent_doc_number] => 20100068137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'Dock-and-Lock (DNL) Vaccines for Cancer Therapy' [patent_app_type] => utility [patent_app_number] => 12/544476 [patent_app_country] => US [patent_app_date] => 2009-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 25747 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068137.pdf [firstpage_image] =>[orig_patent_app_number] => 12544476 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/544476
Dock-and-lock (DNL) vaccines for cancer therapy Aug 19, 2009 Issued
Array ( [id] => 7800662 [patent_doc_number] => 08128932 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-06 [patent_title] => 'Anti-VEGFR monoclonal antibody, method of making and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/542239 [patent_app_country] => US [patent_app_date] => 2009-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11057 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/128/08128932.pdf [firstpage_image] =>[orig_patent_app_number] => 12542239 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/542239
Anti-VEGFR monoclonal antibody, method of making and uses thereof Aug 16, 2009 Issued
Array ( [id] => 6468197 [patent_doc_number] => 20100040675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'COMPOSITIONS AND METHODS FOR PROMOTING OR INHIBITING ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 12/538952 [patent_app_country] => US [patent_app_date] => 2009-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 25946 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20100040675.pdf [firstpage_image] =>[orig_patent_app_number] => 12538952 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/538952
Compositions and methods for promoting or inhibiting angiogenesis Aug 10, 2009 Issued
Array ( [id] => 11581799 [patent_doc_number] => 09636420 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-02 [patent_title] => 'Polypeptide complex comprising non-peptidyl polymer having three functional ends' [patent_app_type] => utility [patent_app_number] => 13/055406 [patent_app_country] => US [patent_app_date] => 2009-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 9208 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13055406 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/055406
Polypeptide complex comprising non-peptidyl polymer having three functional ends Jul 22, 2009 Issued
Array ( [id] => 6528982 [patent_doc_number] => 20100015161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Composition Comprising In Vitro Expanded T-Lymphocytes and Vessel Formation Inhibitors Suitable in the Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 12/505156 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14903 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015161.pdf [firstpage_image] =>[orig_patent_app_number] => 12505156 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/505156
Composition Comprising In Vitro Expanded T-Lymphocytes and Vessel Formation Inhibitors Suitable in the Treatment of Cancer Jul 16, 2009 Abandoned
Array ( [id] => 6625714 [patent_doc_number] => 20100034837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'ANTHRACYCLINE DERIVATIVE CONJUGATES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/502433 [patent_app_country] => US [patent_app_date] => 2009-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 47080 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20100034837.pdf [firstpage_image] =>[orig_patent_app_number] => 12502433 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/502433
Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds Jul 13, 2009 Issued
Array ( [id] => 6183969 [patent_doc_number] => 20110123551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'HVEM/BTLA, HVEM/CD 160 AND HVEM/GD CIS COMPLEXES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/003191 [patent_app_country] => US [patent_app_date] => 2009-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 25520 [patent_no_of_claims] => 105 [patent_no_of_ind_claims] => 40 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123551.pdf [firstpage_image] =>[orig_patent_app_number] => 13003191 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/003191
HVEM/BTLA, HVEM/CD 160 and HVEM/gD cis complexes and methods of use Jul 7, 2009 Issued
Array ( [id] => 6187863 [patent_doc_number] => 20110171242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'LIGAND FOR HERPES SIMPLEX VIRUS ENTRY MEDIATOR AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/498256 [patent_app_country] => US [patent_app_date] => 2009-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 37647 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171242.pdf [firstpage_image] =>[orig_patent_app_number] => 12498256 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/498256
LIGAND FOR HERPES SIMPLEX VIRUS ENTRY MEDIATOR AND METHODS OF USE Jul 5, 2009 Abandoned
Array ( [id] => 6096405 [patent_doc_number] => 20110003382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'USE OF CORTICOSTERONE FOR INCREASING EGG ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/496223 [patent_app_country] => US [patent_app_date] => 2009-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6900 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003382.pdf [firstpage_image] =>[orig_patent_app_number] => 12496223 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/496223
USE OF CORTICOSTERONE FOR INCREASING EGG ANTIBODY Jun 30, 2009 Abandoned
Array ( [id] => 7731561 [patent_doc_number] => 20120014958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF' [patent_app_type] => utility [patent_app_number] => 13/000423 [patent_app_country] => US [patent_app_date] => 2009-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 29018 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20120014958.pdf [firstpage_image] =>[orig_patent_app_number] => 13000423 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/000423
Stable and soluble antibodies inhibiting VEGF Jun 24, 2009 Issued
Array ( [id] => 5473048 [patent_doc_number] => 20090246214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'FUSION PROTEINS CONTAINING RECOMBINANT CYTOTOXIC RNASES' [patent_app_type] => utility [patent_app_number] => 12/479250 [patent_app_country] => US [patent_app_date] => 2009-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12136 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246214.pdf [firstpage_image] =>[orig_patent_app_number] => 12479250 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/479250
Fusion proteins containing recombinant cytotoxic RNAses Jun 4, 2009 Issued
Array ( [id] => 6080100 [patent_doc_number] => 20110142839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'TREATMENT OF PULMONARY EDEMA' [patent_app_type] => utility [patent_app_number] => 12/995389 [patent_app_country] => US [patent_app_date] => 2009-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18087 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142839.pdf [firstpage_image] =>[orig_patent_app_number] => 12995389 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/995389
TREATMENT OF PULMONARY EDEMA May 28, 2009 Abandoned
Array ( [id] => 8146289 [patent_doc_number] => 08163291 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses' [patent_app_type] => utility [patent_app_number] => 12/468589 [patent_app_country] => US [patent_app_date] => 2009-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 28 [patent_no_of_words] => 22375 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163291.pdf [firstpage_image] =>[orig_patent_app_number] => 12468589 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/468589
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses May 18, 2009 Issued
Array ( [id] => 5551766 [patent_doc_number] => 20090285752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'IMMUNOTHERAPY OF B CELL MALIGNANCIES AND AUTOIMMUNE DISEASES USING UNCONJUGATED ANTIBODIES AND CONJUGATED ANTIBODIES AND ANTIBODY COMBINATIONS AND FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/467645 [patent_app_country] => US [patent_app_date] => 2009-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13307 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285752.pdf [firstpage_image] =>[orig_patent_app_number] => 12467645 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/467645
IMMUNOTHERAPY OF B CELL MALIGNANCIES AND AUTOIMMUNE DISEASES USING UNCONJUGATED ANTIBODIES AND CONJUGATED ANTIBODIES AND ANTIBODY COMBINATIONS AND FUSION PROTEINS May 17, 2009 Abandoned
Array ( [id] => 7711906 [patent_doc_number] => 08093018 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-10 [patent_title] => 'Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same' [patent_app_type] => utility [patent_app_number] => 12/467853 [patent_app_country] => US [patent_app_date] => 2009-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 10952 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/093/08093018.pdf [firstpage_image] =>[orig_patent_app_number] => 12467853 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/467853
Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same May 17, 2009 Issued
Array ( [id] => 9936897 [patent_doc_number] => 08986702 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-24 [patent_title] => 'Antibodies and processes for preparing the same' [patent_app_type] => utility [patent_app_number] => 12/467957 [patent_app_country] => US [patent_app_date] => 2009-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 49495 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12467957 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/467957
Antibodies and processes for preparing the same May 17, 2009 Issued
Array ( [id] => 6314142 [patent_doc_number] => 20100111942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/465051 [patent_app_country] => US [patent_app_date] => 2009-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 31414 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20100111942.pdf [firstpage_image] =>[orig_patent_app_number] => 12465051 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/465051
Combination therapy for the treatment of ocular neovascular disorders May 12, 2009 Issued
Array ( [id] => 5515415 [patent_doc_number] => 20090215722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Inhibition of Antigen Presentation with Poorly Catabolized Polymers' [patent_app_type] => utility [patent_app_number] => 12/463315 [patent_app_country] => US [patent_app_date] => 2009-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5211 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215722.pdf [firstpage_image] =>[orig_patent_app_number] => 12463315 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/463315
Inhibition of antigen presentation with poorly catabolized polymers May 7, 2009 Issued
Menu